In order to understand the potential impact of Ozempic, we need to understand the disease it treats and how GLP-1 agonists work
Eli Lilly and Company Today LLY Eli Lilly and Company $1,197.88 +1.85 (+0.15%) As of 03:59 PM Eastern 52-Week Range $623.78 $1,249.45 Dividend Yield 0.58% P/E Ratio 42.55 Price Target $1,283.64 Between these, Novo Nordisk may have the more recognizable brands in the GLP-1 space, as it is the maker of both Ozempic and Wegovy
You administer the medication yourself by injecting the small needle into fatty tissue underneath your skin
New Possibilities in Functional Beverages The infusion of yerba mate into functional food and beverage formulations presents substantial growth opportunities as consumers increasingly seek products that provide multiple health benefits in a single serving
doi: 10.1074/jbc.M708916200 47 HauD
Gastroenterology 135 (4), 13111321